TRAMETINIB EXPERIENCE IN A BRAF P.N 486 _P490DEL MUTATION POSITIVE LANGERHANS CELL HISTIOCYTOSIS

Sevim Gencel Karaaslan(Ankara University), Emel Ünal(Ankara University), Ömer Suat Fitöz(Ankara University), Sonay İncesoy Özdemir(Ankara Yıldırım Beyazıt University), Koray Ceyhan, Handan Dinçaslan(Pediatric Oncology Group), Gül Hatice Erkol Tuncer(Ankara University), Nurdan Taçyıldız(Ankara University), Işınsu Kuzu(Ankara University)
Hematology Transfusion and Cell Therapy
October 1, 2022
10.1016/j.htct.2022.09.1273
Cited by 0

Related Papers

Combined immunodeficiency and Epstein-Barr virus–induced B cell malignancy in humans with inherited CD70 deficiency
|The Journal of Experimental Medicine|2016|153
A 20-year audit of retinoblastoma treatment outcomes
|Eye|2020|38
Successful treatment of central venous catheter infection due to <i>Candida lipolytica</i> by caspofungin‐lock therapy
|Mycoses|2011|35
Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children
|Nutrition and Cancer|2010|30
Retinoblastoma in Turkey: Results From a Tertiary Care Center in Ankara
|Journal of Pediatric Ophthalmology & Strabismus|2013|25